Research Article
Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients
Table 3
Comparison of study variables between survival group and death group (M (Q25 and Q75) or M ± SD).
| | Survival group (N = 68) | Death group (N = 23) | t/U/x2 | P |
| | Male (n (%)) | 52 (76.5) | 17 (73.9) | 0.06 | 0.80 | | Age (years) | 65.1 ± 15.3 | 68.1 ± 13.5 | 0.84 | 0.41 | | BMI (kg/m2) | 22.2 ± 2.4 | 22.1 ± 2.3 | 0.20 | 0.84 | | APACHEⅡscore (points) | 15.5 ± 5.0 | 28.0 ± 5.8 | 9.94 | 0.00 | | STEMI (n (%)) | 52 (76.5) | 17 (73.9) | 0.06 | 0.80 | | cTnI (μg/L) | 47.8 (37.1, 76.6) | 75.1 (47.0, 129.0) | 2.20 | 0.03 | | NT-proBNP (ng/L) | 8949.4 (6950.2, 13822.9) | 13822.9 (6483.4, 19339.0) | 1.41 | 0.16 | | VIS (points) | 14.8 ± 2.9 | 16.4 ± 2.9 | 2.24 | 0.03 | | GAP (mm Hg) | 5.3 ± 0.8 | 6.2 ± 1.3 | 3.94 | 0.00 | | HCY (μmol/L) | 17.8 (12.0, 30.2) | 40.3 (22.2, 58.6) | 4.41 | 0.00 | | Creatinine (μmol/L) | 72.9 (60.1, 91.7) | 95.8 (88.4, 119.2) | 4.35 | 0.00 | | C-reactive protein (mg/L) | 14.3 (6.7, 35.2) | 49.3 (40.5, 68.9) | 5.17 | 0.00 | | HbAlc (%) | 5.7 ± 1.5 | 6.9 ± 1.9 | 3.25 | 0.00 | | CI (L/min/m2) | 2.6 ± 0.6 | 2.2 ± 0.8 | 2.53 | 0.01 | | CD34+/CD133+ cells (%) | 0.50 ± 0.17 | 0.37 ± 0.18 | 19.56 | 0.00 | | CD34+/CD133+/KDR+ cells (%) | 0.19 ± 0.06 | 0.14 ± 0.02 | 28.96 | 0.00 | | CD34+/CD133+ cells quartiles (n (%)) | 49.77 | 0.00 | | Q1 | 5 (21.7) | 18 (78.3) | | | | Q2 | 21 (91.3) | 2 (8.7) | | | | Q3 | 23 (100.0) | 0 (0.0) | | | | Q4 | 20 (90.9) | 2 (9.1) | | | | CD34+/CD133+/KDR+ cells quartiles (n (%)) | 44.04 | 0.00 | | Q1 | 6 (26.1) | 17 (73.9) | | | | Q2 | 17 (73.9) | 6 (26.1) | | | | Q3 | 23 (100.0) | 0 (0.0) | | | | Q4 | 22 (100.0) | 0 (0.0) | | |
|
|
AMI, indicates acute myocardial infarction; STEMI, ST-elevation MI; BMI, body mass index; VIS, vasoactive inotropic score; GAP, central venous-arterial carbon dioxide difference; HCY, homocysteine; CI, cardiac index; AB, atherosclerotic burden.
|
